The A1166C polymorphism of angiotensin II type 1 receptor as a predictor of renal function decline over 4 years follow-up in an apparently healthy Chinese population

Clinical Nephrology

Volumn 72, Issue 6, 2009, Pages 457-467

  Lee, Y T ^a   Chiu, H C ^a   Huang, C T ^a   Su, H M ^b,c   Wang, C L ^a   Lin, T H ^b,c   Voon, W C ^b,c   Chen, H C ^b,c   Lai, W T ^b,c   Sheu, S H ^b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angiotensin II Type 1 receptor; Elderly population; Polymorphism; Renal function decline

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 TYPE 1 RECEPTOR; CREATININE; GENOMIC DNA; NITROGEN; UNCLASSIFIED DRUG; UREA;

ADULT; AGED; ALLELE; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE COURSE; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; POLYMERASE CHAIN REACTION; PREDICTION; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UREA NITROGEN BLOOD LEVEL;

EID: 71449121975     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp72457     Document Type: Article

References (34)

1. Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH. Renoprotective effects of angiotensin II receptor blockade in Type 1 diabetic patients with diabetic nephropathy. Kidney Int. 2000; 57: 601-606.
2. Boffa JJ, Lu Y, Placier S, Stefanski A, Dussaule JC, Chatziantoniou C. Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol. 2003; 14: 1132-1144.
3. Bonnardeaux A, Davies E, Jeunemaitre X, Féry I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F. Angiotensin II Type 1 receptor gene polymorphisms in human essential hypertension. Hypertension. 1994; 24: 63-69.
4. Buraczynska M, Ksiazek P, Drop A, Zaluska W, Spasiewicz D, Ksiazek A. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol Dial Transplant. 2006; 21: 979-983.
5. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41.
6. Coll E, Campos B, González-NúezD, Botey A, Poch E. Association between the A1166C polymorphism of the angiotensin II receptor Type 1 and progression of chronic renal insufficiency. J Nephrol. 2003; 16: 357-364.
7. Díez J, Laviades C, Orbe J, Zalba G, López B, González A, Mayor G, Páramo JA, Beloqui O. The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives. J Hypertens 2003; 21: 2085-2092.
8. Epstein M. Aging and the kidney. J Am Soc Nephrol 1996; 7: 1106-1122.
9. Fliser D, Zeier M, Nowack R, Ritz E. Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol. 1993; 3: 1371-1377.
10. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen-Pope DF, Couser WG, Johnson RJ. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int. 1992; 41: 297-309.
11. Fuiano G, Sund S, Mazza G, Rosa M, Caglioti A, Gallo G, Natale G, Andreucci M, Memoli B, De Nicola L, Conte G. Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. Kidney Int. 2001; 59: 1052-1058.
12. Goyal VK. Changes with age in the human kidney: Exp Gerontol. 1982; 17: 321-331.
13. Hollenberg NK, Adams DF, Solomon HS, Rashid A, Abrams HL, Merrill JP. Senescence and the renal vasculature in normal man. Circ Res. 1974; 34: 309-316.
14. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. J Am Soc Nephrol. 2001; 12: 1315-1325.
15. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int. 1981; 19: 410-415.
16. Hsu CC, Bray MS, Kao WH, Pankow JS, Boerwinkle E, Coresh J. Genetic variation of the renin-angiotensin system and chronic kidney disease progression in black individuals in the atherosclerosis risk in communities study. J Am Soc Nephrol. 2006; 17: 504-512.
17. Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, Parving HH. Progression of diabetic nephropathy in normotensive Type 1 diabetic patients. Kidney Int. 1999; 71 (Suppl): 101-105.
18. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med. 1994; 330: 877-884.
19. Lee YT, Chiu HC, Su HM, Voon WC, Lin TH, Lai WT, Sheu SH. The D allele of angiotensin-converting enzyme polymorphism as a predictor of renal function decline over 4 years in an apparently healthy Chinese population aged 60 and older. J Am Geriatr Soc. 2008; 56: 718-723.
20. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I. Collaborative Study Group: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to Type 2 diabetes. N Engl J Med. 2001; 345: 851-860.
21. Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, Levey AS, Sarnak MJ. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003; 63: 1121-1129.
22. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006; 17: 2937-2944.
23. Meyer BR. Renal function in aging. J Am Geriatr Soc 1989; 37: 791-800.
24. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39 (Suppl): 1-266.
25. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med. 1996; 335: 1636-1642.
26. Parving HH, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR. A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia. 1981; 20: 457-461.
27. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int. 1997; 51: 2-15.
28. Rhoades DA, Welty TK, Wang W, Yeh F, Devereux RB, Fabsitz RR, Lee ET, Howard BV. Aging and the prevalence of cardiovascular disease risk factors in older American Indians: the Strong Heart Study. J Am Geriatr Soc. 2007; 55: 87-94.
29. Rupérez M, Lorenzo O, Blanco-Colio LM, Esteban V, Egido J, Ruiz-Ortega M. Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation. 2003; 108: 1499-1505.
30. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis. 2000; 35 (Suppl): 117-131.
31. Thameem F, Voruganti VS, He X, Nath SD, Blangero J, MacCluer JW, Comuzzie AG, Abboud HE, Arar NH. Genetic variants in the renin-angiotensin system genes are associated with cardiovascular-renal-related risk factors in Mexican Americans. Hum Genet. 2008; 124: 557-559.
32. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiére P. Synergistic effects of angiotensin-converting enzyme and angiotensin-II Type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 1994; 344: 910-913.
33. van Geel PP, Pinto YM, Voors AA, Buikema H, Oosterga M, Crijns HJ, van Gilst WH. Angiotensin II Type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension. 2000; 35: 717-721.
34. Wasen E, Isoaho R, Mattila K, Vahlberg T, Kivela SL, Irjala K. Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C. J Intern Med. 2004; 256: 70-78.